Psychiatry and Neurology, Neurology · Hopedale, MA
NPI
1831283118
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
54 Hopedale St
Hopedale, MA, 01747
Phone (508) 473-4323
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,644 services
Medicare patients, 2024
261
Average age 72
Drug cost, 2024
$3.6M
2,969 prescriptions
Company payments, 2025
$39K
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Pilar Elisa T Dayaw was code 99215 (office e&m - established), 540 times for 207 patients. In total Maria Pilar Elisa T Dayaw billed 1,644 services in 23 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 540 | 207 | $132.64 | $72K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 153 | 20 | $0.10 | $16 |
| 99214 Office E&M - Established | Office | 63 | 50 | $95.47 | $6,015 |
| 99205 Office E&M - New | Office | 62 | 62 | $164.81 | $10K |
| 95885 Electrical Nerve Conductivity | Office | 49 | 23 | $50.69 | $2,484 |
| 99483 Office/Outpatient Services | Office | 24 | 23 | $180.05 | $4,321 |
| 95911 Electrical Nerve Conductivity | Office | 21 | 21 | $171.37 | $3,599 |
| 20552 Musculoskeletal | Office | 20 | 15 | $39.03 | $781 |
By year: 2022 $109K for 2,050 services; 2023 $119K for 1,429 services; 2024 $108K for 1,644 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Pilar Elisa T Dayaw prescribed most often to Medicare patients was Gabapentin, with 302 prescriptions and refills. In total Maria Pilar Elisa T Dayaw wrote 2,969 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 302 | 420 | 61 | $3,912 |
| Memantine Hcl Generic | 209 | 384 | 44 | $11K |
| Donepezil Hcl Generic | 177 | 327 | 40 | $2,047 |
| Teriflunomide Generic | 139 | 167 | 17 | $347K |
| Baclofen Generic | 87 | 179 | 22 | $3,699 |
| Cyclobenzaprine Hcl Generic | 87 | 113 | 21 | $672 |
| Escitalopram Oxalate Generic | 82 | 170 | 15 | $704 |
| Rivastigmine Generic | 80 | 158 | 20 | $23K |
| Kesimpta Pen Ofatumumab | 73 | 73 | Under 11 | $694K |
| Levetiracetam Generic | 66 | 145 | 16 | $1,252 |
| Duloxetine Hcl Generic | 65 | 127 | 20 | $2,134 |
| Lorazepam Generic | 65 | 69 | 23 | $199 |
| Topiramate Generic | 64 | 118 | 16 | $922 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 64 | 64 | Under 11 | $225K |
| Sertraline Hcl Generic | 52 | 102 | Under 11 | $520 |
Brand drugs: 402 claims; generic drugs: 2,555 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Pilar Elisa T Dayaw $39K ($39K in general payments such as food, travel and fees) from 41 companies. The largest payer was Eisai Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 48 | $20K |
| ANI Pharmaceuticals, Inc. ANIP | 14 | $8,322 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $1,924 |
| Biogen, Inc. BIIB | 35 | $1,058 |
| Abbvie Inc. ABBV | 43 | $888 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $651 |
| Lundbeck LLC | 23 | $467 |
| Amneal Pharmaceuticals LLC AMRX | 20 | $418 |
| Pfizer Inc. PFE | 19 | $413 |
| Merz Pharmaceuticals, LLC | 10 | $367 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.